The 2023 Antimicrobial Chemotherapy Conference is just around the corner👀 📅 1 & 2 February 2023 Join the conversation and the global community of #researchers working to tackle rising #AMR and striving for a better tomorrow. Register: bsac.eventsair.com/acc-2023/acc23…

Enrolled in the course "Resistance to antibacterial agents" on FUN: fun-mooc.fr/en/courses/res…

Make sure to not miss our first REVIVE webinar of 2023 on Delivery systems in #antibacterial #drugdiscovery featuring presentations from Ioanna Mela, Claus-Michael Lehr and Sylvain Moineau 👉Register now: attendee.gotowebinar.com/register/36412…

For more information, please visit this website : gdr2038.cnrs.fr/ecole-thematiq…

For more information, please visit this website: gdr2038.cnrs.fr/ecole-thematiq…

📢Calling developers of traditional and non-traditional antimicrobials against priority/medically important pathogens. WHO 2023 data call now open for antibacterials in pre-clinical development!!

Only a few days before our first event! There are a small number of places available. If you are interested, please get in touch before the 13th of March at: [email protected]

5 key challenges solution to improve early stages antibiotic R&D by ReAct - Action on Antibiotic Resistance reactgroup.org/news-and-views…

Please retweet! The BRM lab (Inserm U1230) is actively seeking a motivated post-doc to take on an exciting project involving a novel antimicrobial peptide! 2 years position in the beautiful city of Rennes in France! To apply, find the details below:

Please RT: Open PhD position in Synthetic medicinal chemistry with us Universität Saarland! Project #8 on the site. Deadline May 15! Talents-gradschool.eu

It's time to invest in #antimicrobial R&D now to limit human & economic costs! "We (as a society) are gonna pay now or we're gonna pay later right, but at some point, we're going to pay" Michael Craig from CDC at Duke-Margolis PROMISE - Professional community network on AMR #AMR youtu.be/Dr2Djcfb7qo

It's a date! 🤩 Join us on 6-7 February 2024 for the next Antimicrobial Chemotherapy Conference. For this edition, we're happy to collaborate with Ecraid & NADP🙌 This free online conference is developed by GARDP and BSAC

@antabio announces dosing of the first subjects in its Phase 1 clinical trial of MEM-ANT3310, a next generation treatment of hospital infections caused by carbapenem-resistant Acinetobacter baumannii (#CRAB) and carbapenem-resistant Enterobacterales (#CRE) shorturl.at/gkovS

Congratulations to our member, Entasis Therapeutics on the FDA approval of XACDURO® (sulbactam-durlobactam), a new treatment for #HABP and #VABP caused by susceptible isolates of Acinetobacter baumannii-calcoaceticus complex (ABC). bit.ly/3IEd4r9

Why pull incentives are key to catalysing private investment into antibiotics efpia.eu/news-events/th… via EFPIA

Have you registered yet?! 👀 Join us for our next #REVIVE webinar! Alastair Parkes Evotec and James Duffy Medicines for Malaria Venture (MMV) will discuss SAR optimization & QSAR for #Antimicrobial #DrugDiscovery 🗓️24 August, 4:00PM CEST Free registration 👇 attendee.gotowebinar.com/register/13282…

👥 𝗦𝗮𝘃𝗲 𝗧𝗵𝗲 𝗗𝗮𝘁𝗲 | Journées AntibioDEAL 2024 👉 Les 8 et 9 avril 2024 au Kremlin-Bicêtre, le réseau AntibioDEAL organise ses journées annuelles ❗️ ➡️ amr-promise.fr/fr/francais-sa… ➕ Programme prévisionnel, inscription et infos sur le site dédié : antibiodeal2024.sciencesconf.org

“We cannot improve the clinical ppl w/o investing in preclinical development” Sharp and clear! Damiano de Felice CARB-X BEAM Alliance

We are ready to welcome you for the AntibioDEAL days ! PROMISE - Professional community network on AMR

Prêts pour la 2ème journée annuelle AntibioDEAL ! #antibioresistance #cbsa_lab @paris_saclay